DDD

Business Context and Reporting Period

Company: 3D Systems Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 30, 2001
Business Overview: The company develops, manufactures, and markets solid imaging systems (SLA systems and ThermoJet printers) for rapid prototyping and manufacturing. Revenue is derived from product sales (systems, materials, software) and services (maintenance, training).

Key Financial Metrics

Cash Flow Summary (Q1 2001):

• Net cash used in operating activities: $(1,286) thousand
• Net cash used in investing activities: $(2,712) thousand
• Net cash provided by financing activities: $859 thousand

Material Changes vs. Prior Period

• Revenue Growth: Total sales increased 21.3% year-over-year to $27.9 million. Product sales rose 32.0% driven by a 45.5% increase in SLA systems (specifically the SLA 7000) and a 25.5% increase in materials revenue.
• Service Revenue: Service sales decreased slightly by 1.7% to $7.2 million, attributed to a reduction in time-and-material revenue offset by growth in maintenance contracts.
• Profitability: Operating income improved to $2.1 million (7.5% of revenue) from $1.6 million (6.9% of revenue), aided by higher gross margins and revenue growth despite increased operating expenses.
• Inventory Build: Inventory increased by $1.9 million ($16.8 million vs. $14.9 million), contributing to a $2.7 million cash outflow in operating activities.

Guidance, Outlook, and Risks

Strategic Acquisitions and Mergers:

• DTM Corporation: On April 2, 2001, the company signed a definitive agreement to acquire DTM for approximately $45 million ($5.80/share). Funding is expected via cash on hand, a new $26.5 million revolving credit line, and a $15.0 million term loan. The merger is expected to close in Q2 or Q3 2001.
• OptoForm SARL: Acquired in February 2001 for $2.4 million to expand capabilities in non-liquid stereolithography materials.

Outlook: Management expects continued growth in materials revenue due to an expanding installed base. The company anticipates R&D expenses to remain approximately 8% of sales. The integration of DTM is expected to create synergies in overhead costs and purchasing leverage.

Material Risks and Contingencies:

• DTM Litigation: A class action lawsuit (Spinner v. Goldstein) challenges the adequacy of the DTM merger price. An agreement in principle to settle has been reached, but terms are confidential. Additionally, DTM is involved in significant patent litigation with EOS GmbH, which claims $20 million in damages and threatens breach of contract claims.
• Patent Disputes: Ongoing litigation against Aaroflex (patent infringement) and Teijin Seiki (Japan). The company faces potential invalidation of patents in Japan.
• Supplier Dependence: Reliance on Vantico for liquid photopolymers under an exclusive distribution agreement; termination could materially impact operations.
• Regulatory: The DTM merger is subject to antitrust review by the DOJ and FTC.

Investor Verification Checklist

• DTM Merger Status: Verify the completion of the tender offer (targeting 90% acceptance) and the finalization of the $41.5 million credit facility with US Bank.
• Legal Exposure: Monitor the outcome of the EOS v. DTM litigation and the settlement terms of the Spinner v. Goldstein class action, as these could result in significant damages or injunctions.
• Inventory Levels: Assess the $16.8 million inventory balance against future sales forecasts to ensure no write-downs are required due to slow-moving parts.
• Supplier Agreement: Confirm the stability of the exclusive distribution agreement with Vantico for critical resin supplies.
• Integration Costs: Track actual integration expenses and synergies realized from the DTM and OptoForm acquisitions against management projections.